Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vunakizumab in Adults With Active Psoriatic Arthritis
CTR20212347Phase 2Completed
- Sponsor
- Suzhou Sundia Biotech Co., Ltd.
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of vunakizumab in psoriatic arthritis (PsA), sponsored by Suzhou Sundia Biotech Co., Ltd.. Started Sep 2021; status: completed.
02
Drugs
vunakizumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on CTR20212347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212347.